| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/04/2011 | US7862814 Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins |
| 01/04/2011 | CA2573307C Use of platelet aggregation inhibitors |
| 01/04/2011 | CA2487060C Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| 01/04/2011 | CA2406240C Hcv anti-core monoclonal antibodies |
| 01/04/2011 | CA2335645C Use of interferon alpha 5 in the treatment of viral liver diseases |
| 01/04/2011 | CA2324165C Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 01/04/2011 | CA2301920C Vaccine |
| 01/04/2011 | CA2285018C Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/04/2011 | CA2268865C Anti-p53 single-chain antibody fragments and their uses |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 01/04/2011 | CA2101774C Test and model for alzheimer's disease |
| 01/04/2011 | CA2068654C Varicella-zoster virus antigen |
| 12/30/2010 | US20100333220 Human tissue factor-producing knock-in non-human animal |
| 12/30/2010 | US20100333219 Methods of protein production using ovomucoid regulatory regions |
| 12/30/2010 | US20100333218 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto |
| 12/30/2010 | US20100331537 Novel surface antigen |
| 12/30/2010 | US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions |
| 12/30/2010 | US20100331527 Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format |
| 12/30/2010 | US20100331523 Heterologous Protein Production Using The Twin Arginine Translocation Pathway |
| 12/30/2010 | US20100331297 Modulation of protein trafficking |
| 12/30/2010 | US20100331255 Compositions and Methods for Increasing Production of Recombinant Gamma-Carboxylated Proteins |
| 12/30/2010 | US20100331251 Polypeptides homologous to vegf and bmp1 |
| 12/30/2010 | US20100331250 Anti-angiogenesis fusion proteins |
| 12/30/2010 | US20100331206 Compositions and methods for early pregnancy diagnosis |
| 12/30/2010 | US20100330618 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 12/30/2010 | US20100330617 Methods of Producing a Secreted Protein |
| 12/30/2010 | US20100330616 Novel endoribonuclease |
| 12/30/2010 | US20100330591 GPCR Expressing Cell Lines and Antibodies |
| 12/30/2010 | US20100330572 Organic compounds |
| 12/30/2010 | US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody |
| 12/30/2010 | US20100330113 Vaccine Antigens |
| 12/30/2010 | US20100330095 Axl antibodies |
| 12/30/2010 | US20100330089 Anti-cd20 therapeutic compositions and methods |
| 12/30/2010 | US20100330080 Antigen binding polypeptides |
| 12/30/2010 | US20100330076 Immunoglobulin fc polypeptides |
| 12/30/2010 | US20100330075 Monoclonal human tumor-specific antibody |
| 12/30/2010 | US20100330073 Methods of treatment using antibodies to neutrokine-alpha |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/30/2010 | US20100330070 Methods Of Making An Antibody And Compositions Thereof |
| 12/30/2010 | US20100330068 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 12/30/2010 | US20100329990 Luminescent markers |
| 12/30/2010 | US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof |
| 12/29/2010 | WO2010150730A1 Process for production of peptide thioester |
| 12/29/2010 | WO2010150230A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives |
| 12/29/2010 | WO2010149016A1 New compound and use thereof |
| 12/29/2010 | EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein |
| 12/29/2010 | EP2267431A2 Gas sensor |
| 12/29/2010 | EP2267146A1 Method of denaturing protein with enzymes |
| 12/29/2010 | EP2267135A2 Protein glycosylation modification in pichia pastoris |
| 12/29/2010 | EP2267125A1 Cancer cell motility and cancer cell infiltration inhibitor |
| 12/29/2010 | EP2267024A1 Production of recombinant il-18 binding protein |
| 12/29/2010 | EP2267010A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP2267009A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP2267008A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP1539228B1 Novel composition and methods for the treatment of immune related diseases |
| 12/29/2010 | EP1497415B1 Methods for detection or modulation of the interaction of a cytokine receptor with its ligand |
| 12/29/2010 | EP1165133B1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 12/29/2010 | EP1127069B1 Method of making a monomeric beta-form of a prion protein |
| 12/29/2010 | CN101932720A Protein scaffolds |
| 12/29/2010 | CN101928745A Preparation method and applications of ant polypeptide |
| 12/29/2010 | CN101928744A Process for extracting active collagen peptide from salmon trout waste |
| 12/29/2010 | CN101928743A Enzymolysis product of spirulina phycocyanin and application thereof |
| 12/29/2010 | CN101928742A Whey protein active peptide with antioxidant activity and preparation method thereof |
| 12/29/2010 | CN101928741A Production method for preparing endomorphin-1 in organic medium system by chemoenzymatic method |
| 12/29/2010 | CN101928740A MMP14 double-target efficient binding peptide, method for obtaining polypeptide structure sequence and application of target compound |
| 12/29/2010 | CN101928739A New preparation method of high-density lipoprotein |
| 12/29/2010 | CN101928728A Method for preparing enterovirus virus-like particle and application thereof |
| 12/29/2010 | CN101928723A Preparation of new apolipoprotein A-II |
| 12/29/2010 | CN101928722A New preparation of apolipoprotein A-IV |
| 12/29/2010 | CN101928721A Preparation of new apolipoprotein C-I |
| 12/29/2010 | CN101928710A Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application |
| 12/29/2010 | CN101928709A Gene sequence, recombinant expression and application of hyalomma asiaticum histamine binding protein (HaHBP) |
| 12/29/2010 | CN101928700A Protein kinase PFTK1 monoclonal antibody and preparation method thereof |
| 12/29/2010 | CN101928686A Bacillus subtilis secreting surfactant |
| 12/29/2010 | CN101928677A Producing strain of lipopeptide compound A21978C and application thereof |
| 12/29/2010 | CN101928670A High-yield bacterial strain of antibiotic, preparation method and usage thereof |
| 12/29/2010 | CN101928348A Human TSHR extracellular fusion protein and preparation method thereof |
| 12/29/2010 | CN101928346A Monoclonal antibody of anti-human tissue kallikrein and preparation method thereof |
| 12/29/2010 | CN101928343A Monoclonal antibodies to the CLFA protein and method of use in treating or preventing infections |
| 12/29/2010 | CN101928335A Fungus antitumor polypeptide nucleotide sequence, and preparation method and applications thereof |
| 12/29/2010 | CN101928331A New compound and application thereof |
| 12/29/2010 | CN101928330A New compound and application thereof |
| 12/29/2010 | CN101497886B Polypeptide of fungal thioredoxin, coding sequence, preparation and use |
| 12/29/2010 | CN101067127B Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells |
| 12/29/2010 | CN101031647B Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli |
| 12/29/2010 | CA2766349A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives |
| 12/29/2010 | CA2766040A1 Process for production of peptide thioester |
| 12/28/2010 | US7858844 Non-human transgenic organism comprising transgene coding non-aggregating chromo- or fluorescent Cnidarian chromo- or fluorescent protein; chemiluminescent labels and molecular biology |
| 12/28/2010 | US7858765 OX40R binding agents |
| 12/28/2010 | US7858762 Expression vector comprising nucleotide sequences coding osmosensitive (os-6) protein for use as tool in enhancing propagation in transgenic bacillus |
| 12/28/2010 | US7858760 Antibodies to protein expressed in prostate cancer |
| 12/28/2010 | US7858757 Immunoglobulin for detecting fetal red blood cells in maternal blood; diagnosing chromosomal or genetic defects in developing fetus |
| 12/28/2010 | US7858754 Nel-related protein type 1 antibody |
| 12/28/2010 | US7858752 Chimeric immunoglobulins for use in diagnosis, prevention and treatment of viral infection |
| 12/28/2010 | US7858742 Lymphoma associated molecules and uses therefor |
| 12/28/2010 | US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 12/28/2010 | US7858353 nucleic acid sequence encoding a polypeptide that exhibits Alpha-L-Arabinofuranosidase activity; degrading, cleaving, or removing polysaccharides including cellulose |
| 12/28/2010 | US7858346 Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein |
| 12/28/2010 | US7858345 Of given amino acid sequence; use in diagnosis and treatment of enzootic pneumonia in swine; kits |